The starvation/oxidation combined IDO-blockade immunotherapy not only strengthened the immune response and stimulated the immune memory through the GOx-activated tumor starvation and recruitment of effector T cells but also effectively relieved the immune tolerance by IDO blocking, remarkably inhibiting tumor growth and metastasis in vivo. The gene discussed is IDO1; the disease is neoplasm.